Skandinaviska Enskilda Banken Ab (Publ) Halozyme Therapeutics, Inc. Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

$19.9 Billion
Q1 2025

A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 67,900 shares of HALO stock, worth $4.27 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

67,900

Previous 32,100 111.53%

Holding current value

$4.27 Million

Previous $1.53 Million 182.4%

% of portfolio

0.02%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 07, 2025	BUY	$47.74 - $65.16 $1.71 Million - $2.33 Million	35,800 Added 111.53%	67,900 $4.33 Million
Q4 2024 Feb 10, 2025	SELL	$42.57 - $61.09 $660,984 - $948,544	-15,527 Reduced 32.6%	32,100 $1.53 Million
Q3 2024 Nov 07, 2024	BUY	$51.3 - $64.42 $2.4 Million - $3.01 Million	46,700 Added 5037.76%	47,627 $2.72 Million
Q2 2024 Aug 13, 2024	BUY	$37.81 - $52.4 $35,049 - $48,574	927 New	927 $48,000
Q2 2023 Aug 07, 2023	SELL	$30.28 - $38.74 $151,400 - $193,700	-5,000 Reduced 31.08%	11,087 $400,000
Q1 2023 May 11, 2023	BUY	$32.86 - $55.7 $148,067 - $250,984	4,506 Added 38.91%	16,087 $614,000
Q4 2022 Feb 08, 2023	SELL	$40.06 - $59.44 $768,871 - $1.14 Million	-19,193 Reduced 62.37%	11,581 $659,000
Q3 2022 Nov 14, 2022	SELL	$38.53 - $51.78 $871,702 - $1.17 Million	-22,624 Reduced 42.37%	30,774 $1.22 Million
Q1 2022 May 11, 2022	SELL	$31.97 - $41.06 $8.62 Million - $11.1 Million	-269,685 Reduced 83.47%	53,398 $2.13 Million
Q4 2021 Feb 10, 2022	SELL	$31.82 - $40.75 $675,188 - $864,674	-21,219 Reduced 6.16%	323,083 $13 Million
Q3 2021 Nov 10, 2021	BUY	$38.47 - $46.42 $5.72 Million - $6.9 Million	148,588 Added 75.92%	344,302 $14 Million
Q1 2021 May 14, 2021	BUY	$39.51 - $51.45 $5.32 Million - $6.93 Million	134,614 Added 220.32%	195,714 $8.16 Million
Q4 2020 Feb 11, 2021	SELL	$25.81 - $43.62 $503,295 - $850,590	-19,500 Reduced 24.19%	61,100 $2.61 Million
Q3 2020 Nov 12, 2020	BUY	$25.74 - $29.63 $1.24 Million - $1.43 Million	48,300 Added 149.54%	80,600 $2.12 Million
Q2 2020 Aug 13, 2020	BUY	$16.25 - $26.81 $524,875 - $865,963	32,300 New	32,300 $866,000

Others Institutions Holding HALO

# of Institutions

582

Shares Held

122M

Call Options Held

308K

Put Options Held

186K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $8.76B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.

Account

Skandinaviska Enskilda Banken Ab (Publ) Halozyme Therapeutics, Inc. Transaction History